Språk:
Valuta:
0 VARER - $0.00 Bonus: 2
Generic Addyi (Flibanserin)
Addyi
Flibanserin is sold under the trade name Addyi and used to treat decreased sexual desire in women who have not gone through menopause and who have never had low sexual desire in the past. Flibanserin is for use only when low sexual desire is not caused by a medical condition, a mental disorder, relationship problems, or by using drugs or other medicines.
Velg Doser: 100mg
100mg
12piller
Addyi $105.83
$88.19
$7.35 per pille
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
Legg til i handlekurven
spare: $0.00
100mg
20piller
Addyi $174.95
$145.79
$7.29 per pille
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
Legg til i handlekurven
spare: $1.20
100mg
32piller
Addyi $276.47
$230.39
$7.20 per pille
+ Gratis standard luftpost tjeneste
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
Legg til i handlekurven
spare: $4.80
100mg
60piller
Addyi $511.91
$426.59
$7.11 per pille
+ Free trackable courier service
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
Legg til i handlekurven
spare: $14.40
100mg
92piller
Addyi $766.79
$638.99
$6.95 per pille
+ Free trackable courier service
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
Legg til i handlekurven
spare: $36.80
100mg
120piller
Addyi $992.51
$827.09
$6.89 per pille
+ Free trackable courier service
+ Pakke levering forsikring
+ Neste bestillinger 10% rabatt
Legg til i handlekurven
spare: $55.20
Package Example
Din bestilling vil bli pakket trygt og sikkert, og normalt innen 24 timer. Dette er nøyaktig hvordan pakken vil se ut (bilder av en ekte leveranse). Den har en størrelse og en utseende som et vanlig privat brev (9.4x4.3x0.3 tommer eller 24x11x0.7cm) og det avslører ikke innholdet
Leveringstid
Levering 14-21 dager 10$ Sporing # tilgjengelig i 4 dager
Gratis standard luftpost service for alle bestillinger med sum på $200 og over
Levering 5-9 dager 30$ Sporing # tilgjengelig i 2 dager
Gratis sporbar tjeneste for alle bestillinger med sum på $300 og over
Frakt over hele verden Konfidensialitet og anonymitet garanti
Trygt og sikkert Discreet looking packages
Afsendelse af ordrer indenfor 24 timer 100% levering success
Attester Produktbeskrivelse
Det er ingen tilbakemeldinger for dette produktet for øyeblikket, men du kan være den første til å legge til en ellers kan du lese mer på tilbakemeldingssiden om relaterte produkter .

Legg Til Anmeldelse

Common use

The main component of Addyi is flibanserin - 100 mg.

Flibanserin preferentially activates 5-HT1A receptors in the prefrontal cortex demonstrating regional selectivity, and has been found to increase dopamine and norepinephrine levels and decrease serotonin levels in the rat prefrontal cortex, actions that were determined to be mediated by activation of the 5-HT1A receptor.



Dosage and direction

Addyi is taken 100 mg orally once per day at bedtime in cases of hypoactive sexual desire disorder (HSDD) treatment.

The onset of the flibanserin effect was seen from the first time point measured after 4 weeks of treatment and maintained throughout the treatment period. You should stop taking Addyi after 4 weeks if there is no improvement in symptoms.

This drug is not indicated to enhance sexual performance, and is not indicated for treatment in postmenopausal women or in men.

Treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.



Precautions

It is strongly recommended to consult your doctor or pharmacist before you start taking flibanserin and especially emphasize if you are allergic to this drug or if you have any other allergies.

You must not drink alcohol while taking Addyi. It may cause you to have dangerously low blood pressure.

Also you should not use Addyi if you have: low blood pressure, a history of alcoholism or drug addiction, liver disease, a history of depression or mental illness, or if you currently drink alcohol.

Some medicines can cause unwanted or dangerous effects when used with Addyi. Your doctor may need to change your treatment plan if you use any of the following drugs: nefazodone, ciprofloxacin, larithromycin, erythromycin, telithromycin, fluconazole, itraconazole, ketoconazole, posaconazole, boceprevir, telaprevir, conivaptan, diltiazem, verapamil, atazanavir, fosamprenavir, indinavir, nelfinavir, ritonavir, saquinavir.

Flibanserin may impair your thinking or reactions. Avoid driving or operating machinery for at least 6 hours after you take this medicine, and until you know how this medicine will affect you. Dizziness or low blood pressure can cause falls or other accidents.

It is not known whether flibanserin will harm an unborn baby. Consult your doctor or pharmacist if you are pregnant or planning to become pregnant.

It is not known whether flibanserin passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.



Contraindications

Do not drink alcohol while taking Addyi. Drinking alcohol with this medicine can cause dangerous or unwanted side effects.

Grapefruit and grapefruit juice may interact with flibanserin and lead to unwanted side effects. Avoid the use of grapefruit products while taking Addyi.

Avoid taking herbal supplement containing: ginkgo biloba, resveratrol, St. John's wort.

Fliban is contra-indicated if patients taking another medicine to treat hypoactive sexual desire disorder or using drugs against high blood pressure.

Fliban is not approved for use by men and children younger than 18 years old.



Possible side effect

Get emergency medical help if you have signs of an allergic reaction to Addyi: hives, difficult breathing, your face, lips, tongue, or throat swelling.

Call your doctor at once if you feeling very drowsy or light-headed like you might pass out.

Common Fliban side effects may include: dizziness, nausea, fatigue, nausea, dry mouth, sleepiness or trouble sleeping.

In case you notice any of these side effects or other not listed above - contact your doctor or pharmacist.



Drug interaction

Taking this medicine with other drugs that make you sleepy or lower your blood pressure can worsen Addyi effect. Consult your doctor before taking Fliban with sleeping pills, narcotic pain medicine, muscle relaxer, or medicine for anxiety, depression, or seizures.

Tell your doctor about all your current medicines and any you start or stop using, especially: cimetidine, ginkgo biloba, resveratrol, St. John's wort.

Your doctor also may need to change your treatment plan if you use any of the following antibiotic, antifungal, antiviral, heart or blood pressure, HIV or AIDS drugs: nefazodone, ciprofloxacin, larithromycin, erythromycin, telithromycin, fluconazole, itraconazole, ketoconazole, posaconazole, boceprevir, telaprevir, conivaptan, diltiazem, verapamil, atazanavir, fosamprenavir, indinavir, nelfinavir, ritonavir, saquinavir.

This list is not complete. Other drugs may interact with flibanserin including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Contact your doctor or pharmacist for more details.



Missed dose

If so happened that you missed a dose - skip it and take the medicine the following day at bedtime. Do not take Fliban in the morning and do not take extra medicine to make up the missed dose.



Overdose

If you think you have used too much of Addyi- seek emergency medical attention or call the Poison Help line at 1-800-222-1222.



Storage

Store Addyi within the room temperature not higher than 77° F (20-25° C). Store away from moisture and heat. Do not store drugs in the bathroom. Keep all drugs out of the reach children and animals.



Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

Attester
Brandon Van Belle fra Belgia
Jeg kunne ikke løse mitt problem med avvist transaksjon via live chat, så jeg måtte ringe dem fordi jeg ønsket å høre en menneskelig stemme og snakke med noen mer kompetente. Alt var ok med kredittkortet mitt, men transaksjonen ble avvist. Jeg kunne avgjøre ...
Peter, Wien
Jeg har prøvd Viagra og Cialis før og må si at Levitra forårsaker mindre bivirkninger skjønt. Jeg hadde fryktelig hodepine med Viagra som gjorde sex umulig noen ganger. Med Levitra glemte jeg om det. Jeg vil anbefale det til alle som har lignende problemer, ...
Edmond fra UK
Hvis det ikke ville være on-line salg av generiske legemidler jeg måtte kaste bort så mye penger på dyre medikamenter. Kvaliteten er god, og det fungerer slik som beskrevet. Jeg vil takke gutta som startet alt dette. Jeg vil plassere min fjerde ordre ...
Les mer...

Forsendelsesmåte

Sikker Betalingsprosess
Nyheter
Lockdown could have been avoided - key findings from Covid inquiry
The long-awaited report is published into how well or badly the government handled the Covid pandemic.
Biggest prostate cancer screening trial in decades begins in UK
The study aims to find the best way to detect prostate cancer - the most common cancer in men in the UK.
The private notes and secret documents that tell the inside story of the UK's Covid response
The Covid inquiry is set to publish its second set of findings looking in detail at the huge political decisions that had to be made in 2020.
Non-smoker diagnosed with lung cancer at 37 demands 'urgent action'
Jules Fielder is using Instagram to raise awareness of lung cancer in young women.